Consumer Healthcare has reached a genuine turning point.

Established growth models and long-held assumptions no longer hold.

The post-pandemic boom is over. Growth is slowing. Competition is intensifying. Macro and microeconomic pressures are forcing difficult trade-offs, leaving many organisations focused on short-term performance at the expense of long-term growth.

Yet the industry is approaching a new era of opportunity, and the moment for change is now.

GLP-1 therapies are creating entirely new growth platforms and forcing companies to rethink innovation, portfolio strategy and investment priorities. Artificial intelligence is transforming how organisations operate and compete. Consumer expectations continue to rise. Retail channels are evolving. Rx-to-OTC Switch, Emerging Markets and even long-established categories such as Cough & Cold demand fresh thinking. Meanwhile, M&A has become a private equity battleground where differentiation increasingly matters more than scale.

After years of restructuring, cost reduction and ownership change, leadership teams face a critical challenge:

When should they shift from defence to growth, and where should they place their next strategic bets?

The greatest competitive advantages are rarely created when markets are stable. Cautious companies wait for clarity. Winners build the insight, conviction and strategic direction needed to move ahead.

That means answering fundamental questions:

• Where will sustainable growth come from?
• Which business models will succeed?
• Which emerging health platforms best align with your portfolio and capabilities?
• How should you rethink commercial innovation, M&A and go-to-market strategies?

How can you outperform competitors through smarter strategic choices rather than simply greater investment?

New Paradigms 2027 is built around these questions.

Drawing on more than 40 years of Consumer Healthcare expertise, Nicholas Hall challenges conventional thinking and connects the industry's most important strategic shifts into a single integrated narrative, helping leadership teams anticipate change, uncover new growth opportunities and make bolder strategic decisions.

More than a report, New Paradigms 2027 has evolved into an Executive Platform.

The Foundation Report is complemented by four Quarterly Strategic Briefings, ensuring executive teams maintain a current view of key developments, continuously reassess priorities and act before competitors do.

The strategic agenda has been defined. The scope of New Paradigms 2027 is complete.

Request the full scope today!

To find out more or arrange a confidential briefing, contact Marta Babits at marta.babits@nicholashall.com.